Iktos has been recognized as one of the Six Companies Worthy of Note in AI Drug Discovery by Genetic Engineering & Biotechnology News ! We are thankful and proud of this recognition, that highlights our innovative use of generative AI and robotics to accelerate drug discovery.
Featured alongside BenevolentAI, BioXcel Therapeutics, BullFrog AI, JURA Bio, and Phare Bio we are honored to be one of the companies shaping the future of AI in drug discovery.
Please follow this link to access the article.
